Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy, Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01491113
What this trial is testing

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Who this might be right for
Healthy SubjectsRenal Impairments
UCB Pharma 30
Early research (Phase 1)Study completedNCT05431426
What this trial is testing

PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 44
Early research (Phase 1)Study completedNCT05012436
What this trial is testing

Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

Who this might be right for
Healthy VolunteerRenal Impairments
Yuhan Corporation 16
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT05703282
What this trial is testing

Assess the Safety and Pharmacokinetics of AD-104-A

Who this might be right for
Hyperlipidemias
Addpharma Inc. 32
Early research (Phase 1)Study completedNCT05117294
What this trial is testing

ASP0367 in People With Kidneys That do Not Work Well and in Healthy People

Who this might be right for
Renal ImpairmentHealthy Volunteers
Astellas Pharma Global Development, Inc. 13
Early research (Phase 1)Study completedNCT00674856
What this trial is testing

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function

Who this might be right for
Renal Failure
NicOx 32
Early research (Phase 1)Study completedNCT01975337
What this trial is testing

Pharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy Subjects

Who this might be right for
Kidney Failure, Chronic
Debiopharm International SA 16
Early research (Phase 1)Study completedNCT04364464
What this trial is testing

Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Clinical Pharmacology
Bayer 40
Early research (Phase 1)Study completedNCT00715702
What this trial is testing

Safety Study of AZD5672 in Renally Impaired Subjects

Who this might be right for
Renal Impairment
AstraZeneca 40
Early research (Phase 1)Study completedNCT04004195
What this trial is testing

Study to Investigate Safety, Absorption, Elimination, and Drug Effect of BAY2327949 in Participants With Different Renal Function Status

Who this might be right for
Pharmacokinetics
Bayer 32
Early research (Phase 1)Study completedNCT04734275
What this trial is testing

Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers

Who this might be right for
Chronic Kidney Disease
AstraZeneca 16
Early research (Phase 1)Not Yet RecruitingNCT07793929
What this trial is testing

Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Who this might be right for
End Stage Renal DiseaseRenal ImpairmentObesity+1 more
Kailera 32
Early research (Phase 1)Ended earlyNCT05065463
What this trial is testing

To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.

Who this might be right for
End Stage Renal Disease
AstraZeneca 3
Early research (Phase 1)UnknownNCT05515289
What this trial is testing

Study of SHR6390 in Renal Insufficiency and Healthy Subjects

Who this might be right for
Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 30
Early research (Phase 1)Study completedNCT04616027
What this trial is testing

STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT

Who this might be right for
Diabetes Mellitus, Type 2Renal ImpairmentHealthy
Pfizer 42
Not applicableLooking for participantsNCT06981585
What this trial is testing

Physical Impairments in Children With Chronic Renal Failure

Who this might be right for
Chronic Kidney FailureChronic Kidney Diseases
Izmir Democracy University 25
Early research (Phase 1)Study completedNCT01825889
What this trial is testing

Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants

Who this might be right for
Cardiovascular Disease
Eli Lilly and Company 20
Early research (Phase 1)Study completedNCT02048787
What this trial is testing

Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 19
Early research (Phase 1)Study completedNCT01442259
What this trial is testing

An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects

Who this might be right for
Mild Moderateor Severe Renal Impairment
Novartis Pharmaceuticals 48
Next Page